Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
AbCellera Biologics Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
Ticker
Exchange
SIC #
Website
Latest Ticker
ABCL
Nasdaq
2836
www.abcellera.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for AbCellera Biologics Inc.
AbCellera Biologics Inc. (ABCL): A Bull Case Theory
- Jan 17th, 2025 12:53 pm
AbbVie and Simcere Zaiming link to develop trispecific antibody
- Jan 15th, 2025 3:47 pm
AbCellera expands collaboration with AbbVie
- Jan 14th, 2025 2:25 pm
AbCellera Expands Collaboration with AbbVie to Develop Novel T-Cell Engagers for Oncology
- Jan 13th, 2025 2:00 pm
Is AbCellera Biologics Inc. (ABCL) Among the Best Canadian Penny Stocks to Buy According to Analysts?
- Jan 7th, 2025 2:11 pm
US Penny Stocks To Watch In December 2024
- Dec 24th, 2024 1:07 pm
Is AbCellera Biologics (NASDAQ:ABCL) In A Good Position To Invest In Growth?
- Dec 22nd, 2024 12:16 pm
US Penny Stocks To Consider In November 2024
- Nov 25th, 2024 12:09 am
AbCellera to Present at Upcoming Investor Conferences in December and January
- Nov 21st, 2024 9:05 pm
AbCellera Presents Data on Applications of T-Cell Engager Platform at SITC 2024
- Nov 7th, 2024 3:05 pm
AbCellera Biologics Inc. (NASDAQ:ABCL) Just Reported And Analysts Have Been Cutting Their Estimates
- Nov 7th, 2024 12:48 pm
AbCellera Biologics Third Quarter 2024 Earnings: Misses Expectations
- Nov 6th, 2024 12:10 pm
Q3 2024 Abcellera Biologics Inc Earnings Call
- Nov 5th, 2024 4:17 pm
AbCellera Biologics Inc (ABCL) Q3 2024 Earnings Call Highlights: Navigating Challenges with ...
- Nov 5th, 2024 7:11 am
AbCellera Biologics (ABCL) Q3 2024 Earnings Call Transcript
- Nov 5th, 2024 4:00 am
AbCellera Biologics Inc. (ABCL) Reports Q3 Loss, Misses Revenue Estimates
- Nov 4th, 2024 10:55 pm
AbCellera Reports Q3 2024 Business Results
- Nov 4th, 2024 9:05 pm
AbCellera to Present at Upcoming Investor Conferences in November 2024
- Oct 22nd, 2024 8:05 pm
3 Promising Penny Stocks On US Exchanges With Over $600M Market Cap
- Oct 21st, 2024 2:31 pm
Is AbCellera Biologics Inc. (ABCL) the Penny Stock with the Biggest Upside Potential According to Analysts?
- Oct 16th, 2024 12:58 pm
Scroll